22 May 2026 in The Heart Surgery Forum
Background: This study aimed to evaluate and compare the prognostic value of preoperative serum uric acid (UA) levels and the uric acid-to-albumin ratio (UAR) in predicting three-year mortality following isolated coronary artery bypass grafting (CABG).Methods: We screened a total of 480 patients retrospectively, and analysed 184 patients who underwent isolated CABG between January 2021 and January 2023. Preoperative laboratory data, including UA and albumin levels, were recorded, and UAR was calculated.Results: The primary endpoint was all-cause mortality during a three-year follow-up period. Reciever operating characteristic (ROC) curve analysis and multivariable logistic regression were employed to identify independent predictors of mortality. The mean age of the participants was 60.0 ± 9.2 years. ROC curve analysis demonstrated significant predictive ability for both UAR (AUC: 0.767, p = 0.001) and UA (AUC: 0.768, p = 0.001) regarding 3-year mortality. The optimal cut-off value for UAR was 1.6233 (84.6% sensitivity, 56.7% specificity). In multivariable logistic regression models, UAR (OR: 6.701, p = 0.017) and UA (OR: 1.745, p = 0.011) were both identified as independent predictors of mortality, along with age. Although the UA-based model provided slightly better overall calibration (Hosmer-Lemeshow p = 0.109 vs 0.094) and marginally higher explanatory power (Nagelkerke R2: 0.405 vs 0.396). Conclusion: Both preoperative UA and UAR were identified as independent predictors of long-term mortality after isolated CABG and demonstrated significant prognostic utility for three-year survival assessme.
1 January 2026 in Journal of Cardiac Surgery
Background: Conventional risk scoring systems often lack optimization for long‐term prognosis, necessitating the exploration of machine learning (ML) methods in predicting mortality after coronary artery bypass grafting (CABG). This study aimed to identify risk factors for long‐term mortality in isolated CABG patients and compare the performance of ML models with EuroSCORE II. Methods: This single‐center, retrospective study analyzed the 10‐year follow‐up data of 350 patients who underwent isolated CABG between January 2011 and January 2012. The dataset comprised 52 variables, including clinical and procedural data. After preprocessing and SMOTE resampling, ensemble ML models were trained using Lasso‐based feature selection; performance was compared with the full EuroSCORE II model. Result: The best‐performing model utilized the top 8 features selected by Lasso regression, achieving a higher recall (0.768) and F1 score (0.462) compared to the model using the full feature set. The eight most predictive features were X‐clamp time, cardiopulmonary bypass (CPB) time, first‐year blood glucose levels, MACCE, elevated pulmonary artery pressure (PAH), 10th‐year blood glucose levels, intervention for peripheral arterial disease (PAD), and first‐year LDL levels. The ML pipeline (AUC: 0.559) achieved discrimination comparable to EuroSCORE II (AUC: 0.604) ( p = 0.403). Conclusion: ML‐based analysis identified procedural duration, long‐term metabolic control, and PAD‐related variables as key determinants of long‐term mortality after CABG. Notably, MACCE history and elevated PAH further contributed to risk stratification. ML models achieved discrimination comparable to traditional risk scores while offering improved interpretability for long‐term outcomes, suggesting that integration with established clinical scoring systems may enhance patient‐specific mortality prediction.